Perrigo (PRGO) Free Cash Flow (QoQ) (2013 - 2026)
Perrigo (PRGO) Free Cash Flow (QoQ) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.60 Bn | 29.93 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Perrigo | 1.94 Bn | 1.54 Bn | 313.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 153.61% |
| Mar 28, 2026 | -185.73% |
| Dec 31, 2025 | 398.66% |
| Sep 27, 2025 | -47.44% |
| Jun 28, 2025 | 163.00% |
| Mar 29, 2025 | -132.74% |
| Dec 31, 2024 | 1,720.53% |
| Sep 28, 2024 | 179.89% |
| Jun 29, 2024 | 28.68% |
| Mar 30, 2024 | -114.56% |
| Dec 31, 2023 | 96.33% |
| Sep 30, 2023 | 181.76% |
| Jul 1, 2023 | 965.79% |
| Apr 1, 2023 | -103.81% |
| Dec 31, 2022 | 2.25% |
| Oct 1, 2022 | 315.45% |
| Jul 2, 2022 | -177.04% |
| Apr 2, 2022 | 131.46% |
| Dec 31, 2021 | -154.71% |
| Oct 2, 2021 | 424.41% |